MyLinh Duong1, Shofiqul Islam2, Sumathy Rangarajan2, Koon Teo2, Paul M O'Byrne2, Holger J Schünemann3, Ehimario Igumbor4, Jephat Chifamba5, Lisheng Liu6, Wei Li6, Tengku Ismail7, Kiruba Shankar8, Muhammad Shahid9, Krishnapillai Vijayakumar10, Rita Yusuf11, Katarzyna Zatonska12, Aytekin Oguz13, Annika Rosengren14, Hossain Heidari15, Wael Almahmeed16, Rafael Diaz17, Gustavo Oliveira18, Patricio Lopez-Jaramillo19, Pamela Seron20, Kieran Killian2, Salim Yusuf3. 1. Population Health Research Institute, Department of Medicine, Hamilton, ON, Canada. Electronic address: duongmy@mcmaster.ca. 2. Population Health Research Institute, Department of Medicine, Hamilton, ON, Canada. 3. Department of Clinical Epidemiology and Biostatistics, McMaster University, Hamilton, ON, Canada. 4. School of Public Health, University of the Western Cape, Cape Town, South Africa. 5. Physiology Department, University of Zimbabwe Medical School, Harare, Zimbabwe. 6. National Centre of Cardiovascular Disease, Cardiovascular Institute and Fuwai Hospital, Beijing, China. 7. Faculty of Medicine, Universiti Teknologi MARA, Shah Alam, Malaysia. 8. Epidemiology and Biostatistics, St John's Research Institute, Bangalore, India. 9. Department of Emergency Medicine, Aga Khan University, Karachi, Pakistan. 10. Health Action by People, Trivandrum, India. 11. Independent University Bangladesh, Bashundhara, Dhaka, Bangladesh. 12. Department of Social Medicine, Wrocław Medical University, Wrocław, Poland. 13. Goztepe Training and Research Hospital, Istanbul, Turkey. 14. Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden. 15. Isfahan Cardiovascular Research Center, Isfahan University of Medical Sciences, Isfahan, Iran. 16. Division of Cardiology, Sheikh Khalifa Medical City, Abu Dhabi, United Arab Emirates. 17. Estudios Clínicos Latinoamérica, Rosario, Argentina. 18. Coronary Care Unit, Translational Epidemiology Division, Dante Pazzanese Institute of Cardiology, São Paulo, Brazil. 19. Fundación Oftalmológica de Santander, Floridablanca, Santander, Colombia. 20. Universidad de La Frontera, Temuco, Chile.
Abstract
BACKGROUND: Despite the rising burden of chronic respiratory diseases, global data for lung function are not available. We investigated global variation in lung function in healthy populations by region to establish whether regional factors contribute to lung function. METHODS: In an international, community-based prospective study, we enrolled individuals from communities in 17 countries between Jan 1, 2005, and Dec 31, 2009 (except for in Karnataka, India, where enrolment began on Jan 1, 2003). Trained local staff obtained data from participants with interview-based questionnaires, measured weight and height, and recorded forced expiratory volume in 1 s (FEV₁) and forced vital capacity (FVC). We analysed data from participants 130-190 cm tall and aged 34-80 years who had a 5 pack-year smoking history or less, who were not affected by specified disorders and were not pregnant, and for whom we had at least two FEV₁ and FVC measurements that did not vary by more than 200 mL. We divided the countries into seven socioeconomic and geographical regions: south Asia (India, Bangladesh, and Pakistan), east Asia (China), southeast Asia (Malaysia), sub-Saharan Africa (South Africa and Zimbabwe), South America (Argentina, Brazil, Colombia, and Chile), the Middle East (Iran, United Arab Emirates, and Turkey), and North America or Europe (Canada, Sweden, and Poland). Data were analysed with non-linear regression to model height, age, sex, and region. FINDINGS: 153,996 individuals were enrolled from 628 communities. Data from 38,517 asymptomatic, healthy non-smokers (25,614 women; 12,903 men) were analysed. For all regions, lung function increased with height non-linearly, decreased with age, and was proportionately higher in men than women. The quantitative effect of height, age, and sex on lung function differed by region. Compared with North America or Europe, FEV1 adjusted for height, age, and sex was 31·3% (95% CI 30·8-31·8%) lower in south Asia, 24·2% (23·5-24·9%) lower in southeast Asia, 12·8% (12·4-13·4%) lower in east Asia, 20·9% (19·9-22·0%) lower in sub-Saharan Africa, 5·7% (5·1-6·4%) lower in South America, and 11·2% (10·6-11·8%) lower in the Middle East. We recorded similar but larger differences in FVC. The differences were not accounted for by variation in weight, urban versus rural location, and education level between regions. INTERPRETATION: Lung function differs substantially between regions of the world. These large differences are not explained by factors investigated in this study; the contribution of socioeconomic, genetic, and environmental factors and their interactions with lung function and lung health need further clarification. FUNDING: Full funding sources listed at end of the paper (see Acknowledgments).
BACKGROUND: Despite the rising burden of chronic respiratory diseases, global data for lung function are not available. We investigated global variation in lung function in healthy populations by region to establish whether regional factors contribute to lung function. METHODS: In an international, community-based prospective study, we enrolled individuals from communities in 17 countries between Jan 1, 2005, and Dec 31, 2009 (except for in Karnataka, India, where enrolment began on Jan 1, 2003). Trained local staff obtained data from participants with interview-based questionnaires, measured weight and height, and recorded forced expiratory volume in 1 s (FEV₁) and forced vital capacity (FVC). We analysed data from participants 130-190 cm tall and aged 34-80 years who had a 5 pack-year smoking history or less, who were not affected by specified disorders and were not pregnant, and for whom we had at least two FEV₁ and FVC measurements that did not vary by more than 200 mL. We divided the countries into seven socioeconomic and geographical regions: south Asia (India, Bangladesh, and Pakistan), east Asia (China), southeast Asia (Malaysia), sub-Saharan Africa (South Africa and Zimbabwe), South America (Argentina, Brazil, Colombia, and Chile), the Middle East (Iran, United Arab Emirates, and Turkey), and North America or Europe (Canada, Sweden, and Poland). Data were analysed with non-linear regression to model height, age, sex, and region. FINDINGS: 153,996 individuals were enrolled from 628 communities. Data from 38,517 asymptomatic, healthy non-smokers (25,614 women; 12,903 men) were analysed. For all regions, lung function increased with height non-linearly, decreased with age, and was proportionately higher in men than women. The quantitative effect of height, age, and sex on lung function differed by region. Compared with North America or Europe, FEV1 adjusted for height, age, and sex was 31·3% (95% CI 30·8-31·8%) lower in south Asia, 24·2% (23·5-24·9%) lower in southeast Asia, 12·8% (12·4-13·4%) lower in east Asia, 20·9% (19·9-22·0%) lower in sub-Saharan Africa, 5·7% (5·1-6·4%) lower in South America, and 11·2% (10·6-11·8%) lower in the Middle East. We recorded similar but larger differences in FVC. The differences were not accounted for by variation in weight, urban versus rural location, and education level between regions. INTERPRETATION: Lung function differs substantially between regions of the world. These large differences are not explained by factors investigated in this study; the contribution of socioeconomic, genetic, and environmental factors and their interactions with lung function and lung health need further clarification. FUNDING: Full funding sources listed at end of the paper (see Acknowledgments).
Authors: Lisa LaVange; Sonia M Davis; John Hankinson; Paul Enright; Rebbecca Wilson; R Graham Barr; Thomas K Aldrich; Ravi Kalhan; Hector Lemus; Ai Ni; Lewis J Smith; Gregory A Talavera Journal: Am J Respir Crit Care Med Date: 2017-10-15 Impact factor: 21.405
Authors: Rune Grønseth; William M Vollmer; Jon A Hardie; Inga Sif Ólafsdóttir; Bernd Lamprecht; A Sonia Buist; Louisa Gnatiuc; Amund Gulsvik; Ane Johannessen; Paul Enright Journal: Eur Respir J Date: 2013-10-31 Impact factor: 16.671
Authors: William Checkley; Marilyn G Foreman; Surya P Bhatt; Mark T Dransfield; MeiLan Han; Nicola A Hanania; Nadia N Hansel; Elizabeth A Regan; Robert A Wise Journal: Respir Med Date: 2015-11-11 Impact factor: 3.415
Authors: Raphael E Arku; Aaron Birch; Matthew Shupler; Salim Yusuf; Perry Hystad; Michael Brauer Journal: Environ Int Date: 2018-03-19 Impact factor: 9.621
Authors: Yolandi van Rooyen; Aletta E Schutte; Hugo W Huisman; Fritz C Eloff; Johan L Du Plessis; Annamarie Kruger; Johannes M van Rooyen Journal: Lung Date: 2015-09-28 Impact factor: 2.584
Authors: Raphael E Arku; Michael Brauer; MyLinh Duong; Li Wei; Bo Hu; Lap Ah Tse; Prem K Mony; P V M Lakshmi; Rajamohanan K Pillai; Viswanathan Mohan; Karen Yeates; Lanthe Kruger; Sumathy Rangarajan; Teo Koon; Salim Yusuf; Perry Hystad Journal: Environ Res Date: 2020-06-27 Impact factor: 6.498
Authors: Nicole L Grossman; Victor E Ortega; Tonya S King; Eugene R Bleecker; Elizabeth A Ampleford; Leonard B Bacharier; Michael D Cabana; Juan C Cardet; Tara F Carr; Mario Castro; Loren C Denlinger; Joshua L Denson; Nicolas Fandino; Anne M Fitzpatrick; Gregory A Hawkins; Fernando Holguin; Jerry A Krishnan; Stephen C Lazarus; Sharmilee M Nyenhuis; Wanda Phipatanakul; Sima K Ramratnam; Sally Wenzel; Stephen P Peters; Deborah A Meyers; Michael E Wechsler; Elliot Israel Journal: J Allergy Clin Immunol Date: 2019-09-11 Impact factor: 10.793